Zimmer Biomet sales dip in Q4, sets separation date for ZimVie

Carly Behm -  

Zimmer Biomet saw a 2.3 percent dip in its fourth quarter sales year over year and set a completion date of March 1 for its spine and dental spinoff, ZimVie, on Feb. 7.

Here's what you should know:

1. Fourth quarter revenue was $2 billion, and full-year sales were $7.9 billion, according to financial results.

2. Hip and knee sales saw year-over-year decreases of 4.6 percent and 0.8 percent respectively in the fourth quarter. Hip revenue in the fourth quarter was $480.7 million and $720 million.

3. Spine and dental sales were $260.7 million, down 4.1 percent from the same time last year. 

4. For the full year, hip sales increased 6 percent compared to 2020 and knee sales jumped 11.3 percent. Spine and dental sales rose 12.5 percent.

5. Zimmer Biomet CEO Bryan Hanson said in a news release that COVID-19 surges and hospital staffing shortages affected quarterly sales.

 

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

Featured Learning Opportunities

Featured Webinars

Featured Podcast

Featured Whitepapers